Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors.

Yang N, Li SH, Lü YZ, Chen LS, Ren DM.

Acta Pharmacol Sin. 2011 Mar;32(3):368-74. doi: 10.1038/aps.2010.224.

2.

Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic.

Yang N, Zhu X, Chen L, Li S, Ren D.

Cancer Biol Ther. 2008 Jan;7(1):145-51. Epub 2007 Oct 19.

PMID:
18059172
3.

Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.

Tian Y, Guo B, Jia H, Ji K, Sun Y, Li Y, Zhao T, Gao L, Meng Y, Kalvakolanu DV, Kopecko DJ, Zhao X, Zhang L, Xu D.

Cancer Gene Ther. 2012 Jun;19(6):393-401. doi: 10.1038/cgt.2012.12. Epub 2012 May 4.

4.

Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.

Li Z, Yin PH, Yang SS, Li QY, Chang T, Fang L, Shi LX, Fang GE.

Mol Med Rep. 2013 Apr;7(4):1215-22. doi: 10.3892/mmr.2013.1308. Epub 2013 Feb 5.

PMID:
23404494
5.

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Cancer Res. 2007 Jun 15;67(12):5859-64. Erratum in: Cancer Res. 2010 Jul 1;70(13):5639.

7.

Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.

Li X, Li Y, Wang B, Ji K, Liang Z, Guo B, Hu J, Yin D, Du Y, Kopecko DJ, Kalvakolanu DV, Zhao X, Xu D, Zhang L.

J Cancer Res Clin Oncol. 2013 Jun;139(6):971-80. doi: 10.1007/s00432-013-1398-0. Epub 2013 Mar 5.

8.

RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.

Wang ST, Chang CC, Yen MC, Tu CF, Chu CL, Peng YT, Chen DY, Lan JL, Lin CC.

Gene Ther. 2011 Apr;18(4):372-83. doi: 10.1038/gt.2010.146. Epub 2010 Nov 25.

PMID:
21107437
9.

A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity.

Cheng X, Zhang X, Zhou Y, Zhang C, Hua ZC.

Cancer Biol Ther. 2014 Aug;15(8):1068-76. doi: 10.4161/cbt.29185. Epub 2014 May 19.

10.

Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.

Guo H, Zhang J, Inal C, Nguyen T, Fruehauf JH, Keates AC, Li CJ.

Gene Ther. 2011 Jan;18(1):95-105. doi: 10.1038/gt.2010.112. Epub 2010 Sep 2. Erratum in: Gene Ther. 2011 Jan;18(1):106. Nguyen, T [added]; Fruehauf, J H [added]; Keates, A C [added]; Li, C J [added]. Gene Ther. 2011 Mar;18(3):318.

PMID:
20811467
11.

Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Blache CA, Manuel ER, Kaltcheva TI, Wong AN, Ellenhorn JD, Blazar BR, Diamond DJ.

Cancer Res. 2012 Dec 15;72(24):6447-56. doi: 10.1158/0008-5472.CAN-12-0193. Epub 2012 Oct 22.

12.

shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.

Zou L, Zhang P, Luo C, Tu Z.

Cancer Chemother Pharmacol. 2006 Feb;57(3):328-34. Epub 2005 Jul 19.

PMID:
16028098
13.

Antitumor therapeutic effects of Salmonella typhimurium containing Flt3 Ligand expression plasmids in melanoma-bearing mouse.

Yoon WS, Choi WC, Sin JI, Park YK.

Biotechnol Lett. 2007 Apr;29(4):511-6. Epub 2007 Jan 19.

PMID:
17235489
14.

Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth.

Loeffler M, Le'Negrate G, Krajewska M, Reed JC.

Cancer Immunol Immunother. 2009 May;58(5):769-75. doi: 10.1007/s00262-008-0555-9. Epub 2008 Jul 17.

PMID:
18633610
15.

Tumor-targeting amino acid auxotrophic Salmonella typhimurium.

Hoffman RM.

Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Review.

PMID:
19291366
16.

Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.

Lee CH, Wu CL, Shiau AL.

J Gene Med. 2004 Dec;6(12):1382-93.

PMID:
15468191
17.

Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors.

Fu W, Lan H, Li S, Han X, Gao T, Ren D.

Cancer Gene Ther. 2008 Jul;15(7):474-84. doi: 10.1038/cgt.2008.19. Epub 2008 Apr 25.

PMID:
18437183
18.

Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer.

Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10170-4. Epub 2007 Jun 4.

19.

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):755-60. Epub 2005 Jan 11.

20.

Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter.

Zhang P, Chen Y, Jiang X, Tu Z, Zou L.

Oncol Rep. 2010 May;23(5):1309-16.

PMID:
20372845
Items per page

Supplemental Content

Write to the Help Desk